- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Emmessar Biotech & Nutrition has announced a board meeting on August 07, 2025, to consider and approve the financial results for the quarter ended June 30, 2025. This upcoming review is key for shareholders to understand the company's recent operational performance. Furthermore, the trading window for the company's equity shares will remain closed until August 09, 2025, ensuring fair play and preventing insider activity before the results are public.